On this week’s episode of the OIS Podcast, Robert Rothman, MD, is joined by Vince Anido, Chairman and CEO of Aerie Pharmaceuticals. 

Vince shares his vision for Aerie, and how his lean, efficient team carefully strategizes every move they make to cultivate products that benefit patients. We learn background on both Vince and Aerie, and how two of Aerie’s products, Rhopressa and Rocklatane, were brought to market in under one year. How has Aerie has made a name for themselves globally within glaucoma, and next in dry eye, and retina?